Results 211 to 220 of about 3,520,446 (404)
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang +10 more
wiley +1 more source
Cost-effectiveness analysis of artificial intelligence (AI) for response prediction of neoadjuvant radio(chemo)therapy in locally advanced rectal cancer (LARC) in the Netherlands. [PDF]
Maas L +16 more
europepmc +1 more source
Internalizing External Accident Costs in Safety Investment Evaluation Using Cost–Benefit Analysis [PDF]
Christina Nikolova
openalex +1 more source
Costs and Cost-Benefit Analysis of the Bihar Rural Livelihoods Project-JEEViKA: Preliminary Evidence
Garima Siwach +3 more
openalex +1 more source
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick +19 more
wiley +1 more source
Determinants of hospitalization expenditure for pediatric congenital heart disease: a single-center study from Xinjiang, China. [PDF]
Jiangabieke L, Azhati A, Xie H.
europepmc +1 more source
Failure rate, repair time and unscheduled O&M cost analysis of offshore wind turbines
J. Carroll, A. McDonald, D. McMillan
semanticscholar +1 more source
Ezgi Çiçek +4 more
semanticscholar +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source

